COVID-19 vaccine collides with drug price fervor
Three pharma companies launch the first human clinical trials of experimental COVID-19 drugs and vaccines.
Regulatory
Coronavirus isn’t the only thing on FDA’s mind
Drugs are still being approved and reports are still churning out, all while the FDA battles the COVID-19 outbreak.
FDA and CDC promote telemedicine during COVID-19 outbreak
The federal health agencies have taken steps to provide better telemedicine services during the outbreak.
FDA: Studies underway to evaluate chloroquine for COVID-19
Chloroquine is being investigated as a potential treatment for patients with mild to moderate COVID-19, to reduce the duration of symptoms as well as viral shedding.
A look at the first human trial of a COVID-19 vaccine
A separate trial is evaluating a treatment for patients already sick with COVID-19.
CMS announces major shift to expand telehealth Medicare coverage to nursing home beneficiaries, others as COVID-19 strategy
The federal government is stripping away barriers to Medicare telehealth coverage as a frontline response to the coronavirus outbreak, which feeds on person-to-person contact and has proven deadliest for elderly individuals.
FDA takes additional action to expedite availability of COVID-19 tests
The Food and Drug Administration has announced that it will not object to the New York State Department of Health authorizing certain laboratories in New York to start testing patients for coronavirus disease 2019 once the tests have been validated.
FDA, FTC crack down on fraudulent COVID-19 ‘treatments’
Unapproved products are being marketed as coronavirus 2019 cures
FDA provided a CBD update, but little new information
The FDA said its focus going forward was education, research and enforcement.
Trump and officials meet with pharma on coronavirus treatments
President Trump wanted to know how quickly pharma could have a vaccine or treatment ready for public use.
Want to read more?
Please login or register first to view this content.
